Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Where's Your Application? FDA May Soon Have An App For That

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency's transparency initiative may include a tracking system similar to Health Canada's so that reviewers can avoid having to field phone calls from sponsors asking about the status of an application.

You may also be interested in...



Social Media Could Improve Compliance, Enforcement Transparency, FDA Says

FDA report on increasing public access to compliance and enforcement data recommends that the agency deploy new electronic tools and assess stakeholder need for mobile Web applications.

Transparency Phase III: FDA Offers Designs For Industry Review

FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure

The departure of Principal Deputy Commissioner Joshua Sharfstein provides FDA an opportunity to take stock of its relationship with the new Congress and to re-evaluate its own organizational structure.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel